Chemycal has been acquired by 3E
Learn MoreChemycal has been acquired by 3E
Learn More
Discover how Chemycal PRO helps you boosting your regulatory monitoring:
The Minutes of the Working Group Meeting on Cosmetic Ingredients includes the following items:
New mandates or information from DG GROW
(*) Opinion on Butylparaben
(*) Scientific advice for Homosalate used in face products (face cream and pump spray)
(*) Opinion on new hair dye Sodium Bromothymol Blue (C186)
(*) Potential mandate for revising the Opinion on TiO2
Draft Opinions discussed
(*) Kojic acid: the draft preliminary Opinion has been presented and will be further discussed at the plenary meeting.
(*) Genistein: the draft preliminary Opinion has been presented and will be further discussed at the plenary meeting.
(*) Daidzein: the draft preliminary Opinion has been presented and will be further discussed at the plenary meeting.
(*) Revision of the Vitamin A Opinion: the draft preliminary Opinion has been presented and will be further discussed at the plenary meeting.
(*) Aluminium (aggregate exposure): the draft preliminary Opinion has been presented and will be further discussed at the plenary meeting. A request for clarification to the Applicant is under preparation.
(*) 4-Methylbenzylidene camphor (4-MBC): the draft preliminary Opinion has been presented and will be further discussed at the plenary meeting.
(*) Scientific Advice (SA) on Triclocarban and Triclosan: the content of the file will be further discussed at the plenary meeting.
(*) Arbutins: the draft preliminary Opinion has been presented and will be further discussed at the plenary meeting
Comments on Opinions
(*) Preliminary Opinion on fragrance Methylsalicylate was published and open for comments until 8 September 2021. The Opinion and the SCCS responses to comments received will be finalised for adoption at plenary meeting (26-27 October).
(*) The WG discussed the follow-up of a question received on Lawsonia inermis (Henna) - SCCS/1511/13
The following preliminary opinions have been published for comment until 23 November 2021
(*) Butylated Hydroxytoluene (BHT)
(*) Prostaglandin and analogues
CONTINUE READING ON ec.europa.eu
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions